Endometrial Intraepithelial Neoplasia, Concurrent Endometrial Cancer and Risk for Pelvic Sentinel Node Metastases
(2024) In Cancers 16(24). p.1-11- Abstract
BACKGROUND/OBJECTIVES: Given the risk of a progression, or an undiagnosed endometrial cancer (EC), the treatment of choice is hysterectomy in women with endometrial intraepithelial neoplasia (EIN). The risk of metastatic disease and whether sentinel node (SLN) biopsy should be performed remains unclear. The primary aim of this prospective study was to determine the overall incidence of concurrent EC and the impact of the diagnostic tool used and the type of endometrial lesion. The secondary aim was to investigate the risk of metastatic SLNs.
METHODS: Between July 2019 and May 2024, 98 consecutive women with EIN deemed suitable for robotic surgery and SLN dissection were included in the study. Ultrastaging and immunohistochemistry... (More)
BACKGROUND/OBJECTIVES: Given the risk of a progression, or an undiagnosed endometrial cancer (EC), the treatment of choice is hysterectomy in women with endometrial intraepithelial neoplasia (EIN). The risk of metastatic disease and whether sentinel node (SLN) biopsy should be performed remains unclear. The primary aim of this prospective study was to determine the overall incidence of concurrent EC and the impact of the diagnostic tool used and the type of endometrial lesion. The secondary aim was to investigate the risk of metastatic SLNs.
METHODS: Between July 2019 and May 2024, 98 consecutive women with EIN deemed suitable for robotic surgery and SLN dissection were included in the study. Ultrastaging and immunohistochemistry were performed on all SLNs.
RESULTS: In total, 47% of women with preoperative EIN had EC on final histology; 13% of these had metastatic SLNs and the overall risk of metastases was 6.3%. Women who obtained their diagnosis by an endometrial biopsy had 65% risk of EC. All women with metastatic SLNs had non-polypoid lesions and five out of six obtained their diagnosis through endometrial biopsy.
CONCLUSIONS: The overall risk of SLN metastases was 6.3%, all in women with a general endometrial thickening and/or a diagnosis of EIN by office endometrial biopsy, suggesting that SLN detection should be offered particularly to women with EIN who fulfill these preoperative criteria.
(Less)
- author
- Hawez, Tabayi LU ; Bollino, Michele LU ; Lönnerfors, Celine LU and Persson, Jan LU
- organization
- publishing date
- 2024-12-18
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Cancers
- volume
- 16
- issue
- 24
- article number
- 4215
- pages
- 1 - 11
- publisher
- MDPI AG
- external identifiers
-
- scopus:85213350740
- pmid:39766114
- ISSN
- 2072-6694
- DOI
- 10.3390/cancers16244215
- language
- English
- LU publication?
- yes
- id
- ffa2acd0-0096-4e2b-a4b3-c4f021ab2378
- date added to LUP
- 2026-04-23 09:24:13
- date last changed
- 2026-07-04 15:06:33
@article{ffa2acd0-0096-4e2b-a4b3-c4f021ab2378,
abstract = {{<p>BACKGROUND/OBJECTIVES: Given the risk of a progression, or an undiagnosed endometrial cancer (EC), the treatment of choice is hysterectomy in women with endometrial intraepithelial neoplasia (EIN). The risk of metastatic disease and whether sentinel node (SLN) biopsy should be performed remains unclear. The primary aim of this prospective study was to determine the overall incidence of concurrent EC and the impact of the diagnostic tool used and the type of endometrial lesion. The secondary aim was to investigate the risk of metastatic SLNs.</p><p>METHODS: Between July 2019 and May 2024, 98 consecutive women with EIN deemed suitable for robotic surgery and SLN dissection were included in the study. Ultrastaging and immunohistochemistry were performed on all SLNs.</p><p>RESULTS: In total, 47% of women with preoperative EIN had EC on final histology; 13% of these had metastatic SLNs and the overall risk of metastases was 6.3%. Women who obtained their diagnosis by an endometrial biopsy had 65% risk of EC. All women with metastatic SLNs had non-polypoid lesions and five out of six obtained their diagnosis through endometrial biopsy.</p><p>CONCLUSIONS: The overall risk of SLN metastases was 6.3%, all in women with a general endometrial thickening and/or a diagnosis of EIN by office endometrial biopsy, suggesting that SLN detection should be offered particularly to women with EIN who fulfill these preoperative criteria.</p>}},
author = {{Hawez, Tabayi and Bollino, Michele and Lönnerfors, Celine and Persson, Jan}},
issn = {{2072-6694}},
language = {{eng}},
month = {{12}},
number = {{24}},
pages = {{1--11}},
publisher = {{MDPI AG}},
series = {{Cancers}},
title = {{Endometrial Intraepithelial Neoplasia, Concurrent Endometrial Cancer and Risk for Pelvic Sentinel Node Metastases}},
url = {{http://dx.doi.org/10.3390/cancers16244215}},
doi = {{10.3390/cancers16244215}},
volume = {{16}},
year = {{2024}},
}